Clinical Trial Update: Safety Evaluation of the LGL102 in Obese Subjects Treated With OMS102 [NA]

View source ↗

Summary

This document provides a safety evaluation update from a completed trial of LGL102 in obese subjects treated with OMS102.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Obesity

Drugs mentioned

• LGL102
• OMS102

Snippet

Sponsor: IntraPace, Inc | Conditions: Obesity, Morbid Obesity | NA | Status: COMPLETED